Katrien Vansina

Katrien specialises in all aspects of company law, with a particular focus on mergers and acquisitions, private equity, venture capital, and private and public joint ventures.

Image
Katrien Vansina Stibbe

Katrien Vansina

Senior Associate Brussels

Katrien specialises in all aspects of company law, with a particular focus on mergers and acquisitions, private equity, venture capital, and private and public joint ventures.

Katrien Vansina

Senior Associate Brussels

She obtained a master’s degree in Law from KU Leuven in 2018. Katrien also holds a Master of Laws (LL.M.) degree in International Business Law from King’s College London.

She joined the Brussels office of Stibbe in 2019.

Languages: Dutch, English, French
Admitted to the Brussels Bar: 2019
Place Rogier in Brussels bustling with crowds and traffic against a backdrop of tall buildings.
Matter
BE Law

Stibbe assisted Foxconn in its majority investment in Magnax

Stibbe assisted Foxconn with acquiring Magnax, a Belgian developer of axial‑flux electric motors, through Foxconn’s subsidiary Pan International. The transaction involved a EUR 35.5 million capital injection in exchange for a majority shareholding.

Continue reading
Urban scene
Matter
BE Law

Stibbe assists Storm with the development and financing of two large-scale battery parks in Belgium

Stibbe assisted Storm throughout all development stages and up to financial close on 24 March 2026 of a €330 million equity and debt financing for the development of two large-scale battery energy storage systems (BESS) in Belgium.

Continue reading
Hotel bar
Matter
BE Law

Stibbe assists Schoolkracht

Stibbe assisted Schoolkracht, a private consortium consisting of AG Real Estate, EPICO², Rebel and Ethias, with the realisation of a DBFM (Design, Build, Finance, Maintain) programme for the first cluster of 27 Schools of Flanders.

Continue reading
Cropped close-up of a pharmacy's green cross sign
Matter
NL Law
EU Law

Stibbe advises Medios AG

Stibbe advises Medios on its acquisition of Ceban for around EUR 260 mio. Medios is a German pharmaceutical company listed on the Frankfurt stock exchange. Dutch Ceban prepares medicines for hospitals and pharmacies, also known as compounding.

Continue reading

Publications & Insights